SE355578B - - Google Patents

Info

Publication number
SE355578B
SE355578B SE10206/70A SE1020670A SE355578B SE 355578 B SE355578 B SE 355578B SE 10206/70 A SE10206/70 A SE 10206/70A SE 1020670 A SE1020670 A SE 1020670A SE 355578 B SE355578 B SE 355578B
Authority
SE
Sweden
Application number
SE10206/70A
Inventor
H Laurent
K Kolb
R Wiechert
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of SE355578B publication Critical patent/SE355578B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE10206/70A 1969-07-24 1970-07-23 SE355578B (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1938218A DE1938218C3 (de) 1969-07-24 1969-07-24 9 a,21,21-Trichlor-ll ß-fluor- pregnene, Verfahren zu deren Herstellung sowie diese enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
SE355578B true SE355578B (fr) 1973-04-30

Family

ID=5741103

Family Applications (1)

Application Number Title Priority Date Filing Date
SE10206/70A SE355578B (fr) 1969-07-24 1970-07-23

Country Status (18)

Country Link
US (1) US3681405A (fr)
JP (1) JPS4815290B1 (fr)
AT (1) AT300217B (fr)
BE (1) BE753874A (fr)
CH (1) CH557339A (fr)
CS (1) CS161757B2 (fr)
DE (1) DE1938218C3 (fr)
DK (1) DK122454B (fr)
ES (1) ES381790A1 (fr)
FI (1) FI46844C (fr)
FR (1) FR2059554B1 (fr)
GB (1) GB1317194A (fr)
IE (1) IE34401B1 (fr)
IL (1) IL34976A (fr)
NL (1) NL7010876A (fr)
PL (1) PL79781B1 (fr)
SE (1) SE355578B (fr)
ZA (1) ZA704574B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5972922A (en) * 1990-06-11 1999-10-26 Alcon Laboratories, Inc. Steroids which inhibit angiogenesis
LT2805720T (lt) 2008-05-28 2019-09-25 Reveragen Biopharma, Inc. Nehormoniniai steroidiniai nf-kb moduliatoriai, skirti ligoms gydyti
US9198921B2 (en) 2010-04-05 2015-12-01 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-κB for treatment of disease
US10799514B2 (en) 2015-06-29 2020-10-13 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-kappa beta for treatment of disease
US11382922B2 (en) 2019-03-07 2022-07-12 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3236866A (en) * 1959-04-08 1966-02-22 Syntex Corp 21, 21-difluoro pregnenes
US3025312A (en) * 1959-07-14 1962-03-13 Olin Mathieson 9alpha, 11beta-dichloro pregnanes
US3038898A (en) * 1960-11-10 1962-06-12 Syntex Sa 6-fluoromethyl-9alpha, 11beta-dichlorocortical hormones

Also Published As

Publication number Publication date
IE34401B1 (en) 1975-04-30
FR2059554B1 (fr) 1974-06-14
IE34401L (en) 1971-01-24
DE1938218B2 (de) 1978-01-26
DE1938218A1 (de) 1971-02-04
BE753874A (fr) 1971-01-25
IL34976A0 (en) 1970-09-17
DE1938218C3 (de) 1978-10-19
FI46844C (fi) 1973-07-10
AT300217B (de) 1972-07-25
DK122454B (da) 1972-03-06
GB1317194A (en) 1973-05-16
ES381790A1 (es) 1972-12-01
NL7010876A (fr) 1971-01-26
ZA704574B (en) 1971-03-31
CH557339A (de) 1974-12-31
PL79781B1 (fr) 1975-06-30
FI46844B (fr) 1973-04-02
CS161757B2 (fr) 1975-06-10
US3681405A (en) 1972-08-01
IL34976A (en) 1973-06-29
FR2059554A1 (fr) 1971-06-04
JPS4815290B1 (fr) 1973-05-14

Similar Documents

Publication Publication Date Title
AU465452B2 (fr)
AU4221168A (fr)
AU450150B2 (fr)
FR2059554B1 (fr)
AU442375B2 (fr)
AU470301B1 (fr)
AU5113869A (fr)
AU470661B1 (fr)
AU6312769A (fr)
CS148492B1 (fr)
AU4923469A (fr)
AU4540468A (fr)
AU4949169A (fr)
AU5077469A (fr)
AU5079269A (fr)
AU5109569A (fr)
CS148394B1 (fr)
AU5228269A (fr)
CH547470A4 (fr)
AU4982068A (fr)
BE741704A (fr)
BE739637A (fr)
BE737664A (fr)
BE732141A (fr)
BE728885A (fr)